EW
Edwards Lifesciences
EW13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 2 funds we track own this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying EW
Top funds mostly trimmed Edwards Lifesciences in Q2 (Apr–Jun)
Buying:
FundsInsidersCongress
- Top funds0 of 2 bought more, 2 sold some. Largest: Wedgewood Partners, $14.9M (3% of its portfolio).
- InsidersNo buys, 41 sales in 12 months.
- CongressNo trades disclosed in the last 12 months.
2 funds$15.2M held1.6% avg. weightQ2: 0 bought / 2 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026